Recent Advances in Green Synthesis of Copper Nanoparticles and Their Therapeutic Delivery Applications
DOI:
https://doi.org/10.62752/ijphi.v3i2.249Keywords:
Green synthesis; Copper nanoparticles; Drug delivery; Nanotechnology; Biomedical applicationAbstract
The environmentally sustainable approach of green synthesis for copper nanoparticles (CuNPs) has emerged as an effective and sustainable method within the field of nanotechnology, offering numerous advantages over traditional physical and chemical methodologies. This technique employs biological sources such as plant extracts, microorganisms, and natural biomolecules as reducing and stabilizing agents, thereby circumventing the use of toxic chemicals and excessive energy consumption. Recent advancements in green synthesis techniques have enabled the controlled production of CuNPs with specific size, shape, surface charge, and stability, which are essential for biomedical applications. CuNPs have demonstrated significant potential in drug delivery due to their unique properties, including high surface area, antimicrobial activity, and the ability to be functionalized for targeted delivery. Green-synthesized CuNPs not only enhance drug solubility but also improve bioavailability and facilitate controlled and sustained drug release. Furthermore, these nanoparticles can be engineered to recognize biological targets, thereby augmenting therapeutic efficacy and minimizing toxicity. Recent studies have also highlighted the application of CuNPs in treating various diseases, such as cancer, infections, and inflammatory conditions. Their antimicrobial and anticancer properties further complement their drug delivery capabilities. Nonetheless, challenges such as potential cytotoxicity, stability issues, and scalability must be addressed to facilitate clinical translation.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 © IJPHI GLOBAL PUBLISHER PVT. LTD.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in the International Journal of Pharmaceutical and Healthcare Innovation (IJPHI) are licensed under the Creative Commons Attribution–NonCommercial 4.0 International License (CC BY-NC 4.0). Authors retain copyright of their work and grant the journal the right of first publication. The published material may be used, shared, and reproduced for non-commercial purposes with proper attribution.
© IJPHI GLOBAL PUBLISHER PVT. LTD.








